{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:16:01Z","timestamp":1784945761484,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T00:00:00Z","timestamp":1353974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s40266-012-0036-x","type":"journal-article","created":{"date-parts":[[2012,12,17]],"date-time":"2012-12-17T20:52:50Z","timestamp":1355777570000},"page":"31-38","source":"Crossref","is-referenced-by-count":23,"title":["Ophthalmic Drugs as Part of Polypharmacy in Nursing Home Residents with Glaucoma"],"prefix":"10.1007","volume":"30","author":[{"given":"Matthias","family":"Huber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marita","family":"K\u00f6lzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Stahlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Bolbrinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Dr\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold","family":"Kreutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"issue":"3","key":"36_CR1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0167-4943(99)00009-6","volume":"28","author":"JW Eichenbaum","year":"1999","unstructured":"Eichenbaum JW, Burton WB, Eichenbaum GM, et al. The prevalence of eye disease in nursing home and non-nursing home geriatric populations. Arch Gerontol Geriatr. 1999;28(3):191\u2013204.","journal-title":"Arch Gerontol Geriatr"},{"issue":"3","key":"36_CR2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0161-6420(89)32880-6","volume":"96","author":"WG Whitmore","year":"1989","unstructured":"Whitmore WG. Eye disease in a geriatric nursing home population. Ophthalmology. 1989;96(3):393\u20138.","journal-title":"Ophthalmology"},{"issue":"7","key":"36_CR3","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archopht.122.7.1019","volume":"122","author":"DS Friedman","year":"2004","unstructured":"Friedman DS, West SK, Munoz B, et al. Racial variations in causes of vision loss in nursing homes: the Salisbury eye evaluation in nursing home groups (SEEING) study. Arch Ophthalmol. 2004;122(7):1019\u201324.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"36_CR4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1525-8610(04)70108-5","volume":"5","author":"JJ Voytas","year":"2004","unstructured":"Voytas JJ, Kowalski D, Wagner S, et al. Eye care in the skilled nursing facility: a pilot study of prevalence and treatment patterns of glaucoma. J Am Med Dir Assoc. 2004;5(3):156\u201360.","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"36_CR5","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1001\/archopht.1993.01090050114040","volume":"111","author":"MH Brenner","year":"1993","unstructured":"Brenner MH, Curbow B, Javitt JC, et al. Vision change and quality of life in the elderly: response to cataract surgery and treatment of other chronic ocular conditions. Arch Ophthalmol. 1993;111(5):680\u20135.","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"36_CR6","first-page":"431","volume":"22","author":"MW Legro","year":"1991","unstructured":"Legro MW. Quality of life and cataracts: a review of patient-centered studies of cataract surgery outcomes. Ophthalmic Surg. 1991;22(8):431\u201343.","journal-title":"Ophthalmic Surg"},{"issue":"6","key":"36_CR7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/ageing\/20.6.392","volume":"20","author":"CA Long","year":"1991","unstructured":"Long CA, Holden R, Mulkerrin E, et al. Opportunistic screening of visual acuity of elderly patients attending outpatient clinics. Age Ageing. 1991;20(6):392\u20135.","journal-title":"Age Ageing"},{"issue":"6","key":"36_CR8","first-page":"327","volume":"46","author":"ME McMurdo","year":"1988","unstructured":"McMurdo ME, Baines PS. The detection of visual disability in the elderly. Health Bull (Edinb). 1988;46(6):327\u20139.","journal-title":"Health Bull (Edinb)"},{"issue":"11","key":"36_CR9","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/S0161-6420(96)30432-6","volume":"103","author":"F Wang","year":"1996","unstructured":"Wang F, Javitt JC. Eye care for elderly Americans with diabetes mellitus: failure to meet current guidelines. Ophthalmology. 1996;103(11):1744\u201350.","journal-title":"Ophthalmology"},{"issue":"6836","key":"36_CR10","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/bmj.304.6836.1226","volume":"304","author":"RP Wormald","year":"1992","unstructured":"Wormald RP, Wright LA, Courtney P, et al. Visual problems in the elderly population and implications for services. BMJ. 1992;304(6836):1226\u20139.","journal-title":"BMJ"},{"issue":"9774","key":"36_CR11","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","volume":"377","author":"HA Quigley","year":"2011","unstructured":"Quigley HA. Glaucoma. Lancet. 2011;377(9774):1367\u201377.","journal-title":"Lancet"},{"issue":"5","key":"36_CR12","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","volume":"31","author":"E Ricciotti","year":"2011","unstructured":"Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011;31(5):986\u20131000.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"36_CR13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1152\/physrev.2000.80.2.681","volume":"80","author":"C Geers","year":"2000","unstructured":"Geers C, Gros G. Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol Rev. 2000;80(2):681\u2013715.","journal-title":"Physiol Rev"},{"key":"36_CR14","volume-title":"Clinical ocular toxicology","year":"2008","unstructured":"Fraunfelder FT, Fraunfelder FW, Chambers WA, editors. Clinical ocular toxicology. Riverport: Saunders; 2008."},{"issue":"6","key":"36_CR15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00417-002-0462-2","volume":"240","author":"JM Korte","year":"2002","unstructured":"Korte JM, Kaila T, Saari KM. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops. Graefes Arch Clin Exp Ophthalmol. 2002;240(6):430\u20135.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"Suppl. 1","key":"36_CR16","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0039-6257(02)00302-8","volume":"47","author":"B Sjoquist","year":"2002","unstructured":"Sjoquist B, Stjernschantz J. Ocular and systemic pharmacokinetics of latanoprost in humans. Surv Ophthalmol. 2002;47(Suppl. 1):S6\u201312.","journal-title":"Surv Ophthalmol"},{"issue":"20","key":"36_CR17","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/jama.1995.03530200047035","volume":"274","author":"TI Edeki","year":"1995","unstructured":"Edeki TI, He H, Wood AJ. Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops: potential for oral-ophthalmic drug interaction. JAMA. 1995;274(20):1611\u20133.","journal-title":"JAMA"},{"issue":"4","key":"36_CR18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1742-7843.2009.00487.x","volume":"106","author":"M Volotinen","year":"2010","unstructured":"Volotinen M, Korjamo T, Tolonen A, et al. Effects of selective serotonin reuptake inhibitors on timolol metabolism in human liver microsomes and cryo-preserved hepatocytes. Basic Clin Pharmacol Toxicol. 2010;106(4):302\u20139.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"36_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1748-3743.2010.00264.x","volume":"6","author":"C Parsons","year":"2011","unstructured":"Parsons C, Lapane K, Kerse N, et al. Prescribing for older people in nursing homes: a review of the key issues. Int J Older People Nurs. 2011;6(1):45\u201354.","journal-title":"Int J Older People Nurs"},{"key":"36_CR20","unstructured":"WHO collaborating centre for drug statistics methodology. Anatomical therapeutic chemical (ATC) classification system. 2012. http:\/\/www.whocc.no\/atc_ddd_index\/ . Accessed 2012 Nov 9."},{"key":"36_CR21","unstructured":"World Health Organization. International statistical classification of diseases and related health problems. 10th ed. 2010. http:\/\/www.who.int\/classifications\/icd\/en\/ . Accessed 2012 Nov 9."},{"key":"36_CR22","unstructured":"European Glaucoma Society. Terminology and guidelines for glaucoma. 3rd ed. 2008. http:\/\/www.eugs.org\/eng\/EGS_guidelines.asp . Accessed 2012 Nov 9."},{"issue":"8","key":"36_CR23","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1017\/S104161021100024X","volume":"23","author":"M Azermai","year":"2011","unstructured":"Azermai M, Elseviers M, Petrovic M, et al. Assessment of antipsychotic prescribing in Belgian nursing homes. Int Psychogeriatr. 2011;23(8):1240\u20138.","journal-title":"Int Psychogeriatr"},{"issue":"5","key":"36_CR24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/gps.2359","volume":"25","author":"PS Nishtala","year":"2010","unstructured":"Nishtala PS, McLachlan AJ, Bell JS, et al. Determinants of antipsychotic medication use among older people living in aged care homes in Australia. Int J Geriatr Psychiatry. 2010;25(5):449\u201357.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"7","key":"36_CR25","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1532-5415.2011.03478.x","volume":"59","author":"C Parsons","year":"2011","unstructured":"Parsons C, Briesacher BA, Givens JL, et al. Cholinesterase inhibitor and memantine use in newly admitted nursing home residents with dementia. J Am Geriatr Soc. 2011;59(7):1253\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"36_CR26","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1532-5415.2010.02819.x","volume":"58","author":"J Tjia","year":"2010","unstructured":"Tjia J, Rothman MR, Kiely DK, et al. Daily medication use in nursing home residents with advanced dementia. J Am Geriatr Soc. 2010;58(5):880\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"36_CR27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1755-3768.2011.02169.x","volume":"89","author":"A Heijl","year":"2011","unstructured":"Heijl A. Perimetry, tonometry and epidemiology: the fate of glaucoma management. Acta Ophthalmol. 2011;89(4):309\u201315.","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"36_CR28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/jop.1991.7.243","volume":"7","author":"TM Phan","year":"1991","unstructured":"Phan TM, Nguyen KP, Giacomini JC, et al. Ophthalmic beta-blockers: determination of plasma and aqueous humor levels by a radioreceptor assay following multiple doses. J Ocul Pharmacol. 1991;7(3):243\u201352.","journal-title":"J Ocul Pharmacol"},{"issue":"6","key":"36_CR29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2165\/00002512-200724060-00007","volume":"24","author":"S Henness","year":"2007","unstructured":"Henness S, Swainston HT, Keating GM. Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertension. Drugs Aging. 2007;24(6):509\u201328.","journal-title":"Drugs Aging"},{"issue":"11","key":"36_CR30","first-page":"976","volume":"114","author":"K Kawase","year":"2010","unstructured":"Kawase K, Yamamoto T, Muramatsu T, et al. Long-acting carteolol hydrochloride 2% ophthalmic solution phase IV study: investigation of the effectiveness, safety and plasma concentration (in Japanese). Nihon Ganka Gakkai Zasshi. 2010;114(11):976\u201382.","journal-title":"Nihon Ganka Gakkai Zasshi"},{"issue":"2","key":"36_CR31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/00365510601034736","volume":"67","author":"T Nieminen","year":"2007","unstructured":"Nieminen T, Lehtimaki T, Maenpaa J, et al. Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects. Scand J Clin Lab Invest. 2007;67(2):237\u201345.","journal-title":"Scand J Clin Lab Invest"},{"issue":"5\u20136","key":"36_CR32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00228-005-0945-2","volume":"61","author":"T Nieminen","year":"2005","unstructured":"Nieminen T, Uusitalo H, Turjanmaa V, et al. Association between low plasma levels of ophthalmic timolol and haemodynamics in glaucoma patients. Eur J Clin Pharmacol. 2005;61(5\u20136):369\u201374.","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"36_CR33","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.ophtha.2011.03.039","volume":"118","author":"S Raber","year":"2011","unstructured":"Raber S, Courtney R, Maeda-Chubachi T, et al. Latanoprost systemic exposure in pediatric and adult patients with glaucoma: a phase 1, open-label study. Ophthalmology. 2011;118(10):2022\u20137.","journal-title":"Ophthalmology"},{"issue":"6","key":"36_CR34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1350-9462(03)00064-8","volume":"22","author":"VP Costa","year":"2003","unstructured":"Costa VP, Harris A, Stefansson E, et al. The effects of antiglaucoma and systemic medications on ocular blood flow. Prog Retin Eye Res. 2003;22(6):769\u2013805.","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"36_CR35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.7326\/0003-4819-155-4-201108160-00009","volume":"155","author":"J Mant","year":"2011","unstructured":"Mant J, Al-Mohammad A, Swain S, et al. Management of chronic heart failure in adults: synopsis of the National Institute for Health and Clinical Excellence guideline. Ann Intern Med. 2011;155(4):252\u20139.","journal-title":"Ann Intern Med"},{"issue":"7","key":"36_CR36","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ophtha.2006.02.062","volume":"113","author":"AJ Lee","year":"2006","unstructured":"Lee AJ, Wang JJ, Kifley A, et al. Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study. Ophthalmology. 2006;113(7):1069\u201376.","journal-title":"Ophthalmology"},{"issue":"5","key":"36_CR37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1742-7843.2011.00694.x","volume":"108","author":"M Volotinen","year":"2011","unstructured":"Volotinen M, Hakkola J, Pelkonen O, et al. Metabolism of ophthalmic timolol: new aspects of an old drug. Basic Clin Pharmacol Toxicol. 2011;108(5):297\u2013303.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"36_CR38","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1046\/j.1532-5415.2002.50226.x","volume":"50","author":"GD Novack","year":"2002","unstructured":"Novack GD, O\u2019Donnell MJ, Molloy DW. New glaucoma medications in the geriatric population: efficacy and safety. J Am Geriatr Soc. 2002;50(5):956\u201362.","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"36_CR39","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-117-8-684","volume":"117","author":"MH Beers","year":"1992","unstructured":"Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med. 1992;117(8):684\u20139.","journal-title":"Ann Intern Med"},{"issue":"3","key":"36_CR40","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1532-5415.2005.53161.x","volume":"53","author":"JA Doshi","year":"2005","unstructured":"Doshi JA, Shaffer T, Briesacher BA. National estimates of medication use in nursing homes: findings from the 1997 medicare current beneficiary survey and the 1996 medical expenditure survey. J Am Geriatr Soc. 2005;53(3):438\u201343.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"36_CR41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0161-6420(79)35544-0","volume":"86","author":"ED Batchelor","year":"1979","unstructured":"Batchelor ED, O\u2019Day DM, Shand DG, et al. Interaction of topical and oral timolol in glaucoma. Ophthalmology. 1979;86(1):60\u20135.","journal-title":"Ophthalmology"},{"issue":"1","key":"36_CR42","first-page":"18","volume":"18","author":"P Blondeau","year":"1983","unstructured":"Blondeau P, Cote M, Tetrault L. Effect of timolol eye drops in subjects receiving systemic propranolol therapy. Can J Ophthalmol. 1983;18(1):18\u201321.","journal-title":"Can J Ophthalmol"},{"issue":"6","key":"36_CR43","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0161-6420(00)00081-6","volume":"107","author":"JS Schuman","year":"2000","unstructured":"Schuman JS. Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2. Ophthalmology. 2000;107(6):1171\u20137.","journal-title":"Ophthalmology"},{"issue":"8","key":"36_CR44","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1442-9071.2007.01573.x","volume":"35","author":"I Goldberg","year":"2007","unstructured":"Goldberg I, Adena MA. Co-prescribing of topical and systemic beta-blockers in patients with glaucoma: a quality use of medicine issue in Australian practice. Clin Exp Ophthalmol. 2007;35(8):700\u20135.","journal-title":"Clin Exp Ophthalmol"},{"issue":"6","key":"36_CR45","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00061198-199712000-00007","volume":"6","author":"MS Gottfredsdottir","year":"1997","unstructured":"Gottfredsdottir MS, Allingham RR, Shields MB. Physicians\u2019 guide to interactions between glaucoma and systemic medications. J Glaucoma. 1997;6(6):377\u201383.","journal-title":"J Glaucoma"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-012-0036-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-012-0036-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-012-0036-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T04:28:56Z","timestamp":1562473736000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-012-0036-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,27]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["36"],"URL":"https:\/\/doi.org\/10.1007\/s40266-012-0036-x","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,27]]}}}